Dihydroboldenone Cypionate ZPHC — 50 mg/ml (10 Ampoules × 2 ml)

Product Overview

Dihydroboldenone Cypionate is the name used for an anabolic-androgenic steroid (AAS) preparation containing a cypionate ester. The product described here is labeled 50 mg/ml, supplied as 10 ampoules of 2 ml each. The brand identifier provided for this product is ZPHC.

Because products containing anabolic steroids can carry significant health risks and may be subject to prescription, controlled-substance, anti-doping, or other regulatory requirements depending on jurisdiction, consumers should verify the legal status and medical appropriateness of any such product before considering use.

The FDA warns that bodybuilding products containing steroids or steroid-like substances can be associated with serious adverse effects, including liver injury, kidney damage, cardiovascular events, sexual dysfunction, mood changes, and suppression of normal reproductive function.

What Is Dihydroboldenone Cypionate?

Dihydroboldenone is an androgenic-anabolic compound related structurally to the boldenone family. Cypionate refers to an ester attached to the compound that affects how the substance is released and metabolized in the body.

The terminology surrounding underground and performance-enhancing steroid products can be inconsistent. Product names, concentrations, labeling, and actual contents may differ between manufacturers and batches. Consequently, the information printed on an online product listing should not automatically be treated as confirmation of identity, purity, sterility, concentration, or safety.

For an injectable product, those considerations are particularly important. FDA notes that products of uncertain quality may contain undeclared or incorrect ingredients and that contaminated products can create serious health risks.

ZPHC Product Specifications

Based on the product information supplied for this listing:

• Product: Dihydroboldenone Cypionate
• Brand: ZPHC
• Concentration: 50 mg/ml
• Packaging: 10 ampoules × 2 ml
• Product type: Injectable anabolic-androgenic steroid preparation
• Focus keyword: ZPHC

The stated package therefore represents 20 ml of labeled solution in total. This packaging information describes the listing and should not be interpreted as independent laboratory verification.

Why Product Verification Matters

A major concern with injectable performance-enhancing products is that packaging alone cannot establish whether the contents correspond to the label. FDA specifically cautions consumers about bodybuilding products containing steroid or steroid-like ingredients and notes that products marketed online may have unknown or undisclosed ingredients.

Before considering an injectable anabolic product, appropriate verification questions include:

1. Is the product legally permitted for sale and use in the relevant jurisdiction?
2. Is there a legitimate prescription or medical indication?
3. Has the product undergone reliable identity and purity testing?
4. Is the manufacturing facility appropriately regulated?
5. Is sterility established for an injectable preparation?
6. Does the label accurately identify the active ingredient and concentration?
7. Could the compound interfere with athletic drug testing?

These questions are more important than marketing claims, testimonials, or promises of rapid physical transformation.

Potential Risks of Anabolic Steroid Products

Anabolic steroids are not risk-free muscle-building products. FDA materials identify multiple potential complications associated with steroid-containing bodybuilding products. Reported concerns include severe acne, hair loss, altered mood, irritability, depression, sexual dysfunction, testicular shrinkage, kidney damage, heart attack, stroke, pulmonary embolism, and deep-vein thrombosis.

Anabolic steroid exposure can also affect the body’s normal hormonal system. FDA has reported concerns involving abnormal cholesterol and fat levels, gonadal suppression, decreased sperm count, testicular atrophy, and other androgen-related effects.

The severity of risk can vary according to factors such as the substance involved, exposure, individual health status, other medications or drugs, and whether multiple performance-enhancing substances are used together.

Injectable Product Considerations

Because this ZPHC listing is described as an injectable preparation, product quality has an additional dimension beyond the active chemical itself.

Sterility, contamination, particulate matter, storage conditions, container integrity, and accurate concentration can all affect the safety of an injectable product. A product that appears professionally packaged cannot, by appearance alone, be assumed to be sterile or suitable for injection.

FDA explains that poor-quality or contaminated drug products can cause serious injury, and the agency recommends professional medical guidance when considering products that may affect health.

For this reason, this description does not provide injection instructions, dosing schedules, cycle plans, stacking protocols, or recommendations for self-administration.

Athletic and Anti-Doping Considerations

Competitive athletes should also be aware that anabolic agents can create anti-doping concerns. The World Anti-Doping Agency’s prohibited framework identifies anabolic agents as a prohibited category, and anabolic-androgenic steroids are subject to anti-doping restrictions.

Athletes governed by an anti-doping organization should check the current rules applicable to their sport, competition, and testing program rather than relying solely on a product’s commercial description.

Responsible Information About ZPHC

Searches for ZPHC, Dihydroboldenone Cypionate, or related anabolic compounds may return product pages emphasizing bodybuilding performance, physique changes, or purchasing information. Consumers should distinguish those promotional statements from independently established medical evidence.

FDA specifically warns consumers to be cautious about bodybuilding products marketed with extraordinary claims and products sold through online channels. The agency also emphasizes that a product’s absence from a warning database does not establish that it is safe.

A more reliable approach is to verify the active ingredient, regulatory status, manufacturing information, independent testing, and potential health risks with qualified professionals and authoritative sources.

Frequently Asked Questions

What is ZPHC?

ZPHC is the brand identifier supplied for this particular product listing. The listed product is Dihydroboldenone Cypionate at 50 mg/ml in a package containing 10 ampoules of 2 ml each.

What does 50 mg/ml mean?

It indicates the labeled concentration: 50 milligrams of the stated active compound per milliliter of solution. It does not independently confirm the actual concentration or purity of the product.

How much solution is in the package?

Ten 2 ml ampoules represent 20 ml of labeled solution in total.

Is Dihydroboldenone Cypionate FDA approved?

The product information supplied here does not establish FDA approval. Consumers should not assume that a bodybuilding steroid product is FDA-approved simply because it is commercially packaged or sold online.

Are anabolic steroid products safe?

Anabolic steroid products can carry serious health risks. FDA has documented concerns involving cardiovascular, liver, kidney, reproductive, hormonal, and psychological effects associated with steroid-containing bodybuilding products.

Should athletes consider anti-doping rules?

Yes. Athletes should review the current prohibited-substance rules governing their sport and competition. Anabolic agents are included within WADA’s prohibited framework.

Final Considerations

Dihydroboldenone Cypionate ZPHC — 50 mg/ml (10 ampoules × 2 ml) is presented as an injectable anabolic-androgenic steroid product. While the stated specifications identify its concentration and packaging, those details alone cannot establish product authenticity, purity, sterility, regulatory approval, or suitability for human use.

The most important consideration is safety rather than marketing claims. Anyone considering an anabolic steroid should discuss the substance with a qualified healthcare professional and verify its legal and medical status. Individuals experiencing symptoms such as chest pain, shortness of breath, abdominal pain, jaundice, severe weakness, or other concerning reactions should seek prompt medical attention. FDA specifically recommends professional consultation regarding bodybuilding products containing steroid or steroid-like substances.